36P BREAKWATER: Post-hoc subgroup efficacy analyses by chemotherapy ± bevacizumab regimens vs encorafenib plus cetuximab + mFOLFOX6
Title:
36P BREAKWATER: Post-hoc subgroup efficacy analyses by chemotherapy ± bevacizumab regimens vs encorafenib plus cetuximab + mFOLFOX6
Author:
Yoshino, T. Kopetz, S. Van Cutsem, E. Wasan, H.S. Eng, C. Yaeger, R. Kim, T.W. Ciardiello, F. Maughan, T. Desai, J. Fernandez, E. Elez Lonardi, S. Shen, L. Raphael, M. Deming, D. Usari, T. King, A. Rezai, N. Zhang, X. Tabernero, J.